Wockhardt Limited Company Profile - Aug 20, 2011

Document Sample
Wockhardt Limited Company Profile - Aug 20, 2011 Powered By Docstoc
					Company Fundamentals\Company Profile

   A Wright Investors' Service Research Report:

   Wockhardt Limited
                                                                                         440 Wheelers Farms Road
                                                                                         Milford, CT 06461 U.S.A.


  COMPANY PROFILE
  Figures in Indian Rupees

                                 Wright Quality Rating:CLNN                                Key Data

   Wockhardt Limited (WL) is an India-based an integrated pharmaceutical,                  Ticker:
   biotechnology and healthcare company. The Company is a subsidiary of Khorakwala         532300
   Holdings and Investments Private Limited. The Company's cardiology division covers
   lifestyle diseases, which include diabetes and nephrology, supported by                 2011 Sales:
   biotechnology products, such as Wosulin, Glaritus and Wepox. As of March 31, 2010,
                                                                                           37,512,400,000
   the Company had seven hospitals with 800 inpatient beds. The Company's
   subsidiaries includes Wockhardt Biopharm Limited, Vinton Healthcare Limited,
   Wockhardt Infrastructure Development Limited, Wockhardt UK Holdings Limited, CP         Major Industry:
   Pharmaceuticals Limited, Wallis Group Limited and The Wallis Laboratory Limited.        Drugs, Cosmetics & Health
                                                                                           Care
                       Stock Chart                                    Officers
                                                                     Chairman
                                                                Habil F. Khorakiwala       Sub Industry:
                                                                                           Ethical Drug Manufacturers
                                                              Chief Financial Officer
                                                                    S. Giridhar            Country:
                                                                                           India
                                                              Vice President Finance
                                                                    Ajay Sahni             Currency:
                                                                                           Indian Rupees
                                                                Managing Director
                                                                  Sirjiwan Singh           Fiscal Year Ends:
                                                                                           March
                                                         Executive Managing Director
                                                           Dr. Murtaza H. Khorakiwala
                                                                                           Employees
                                                                                           7,000

                                                                                           Exchanges:
                                                                                           BOM LUX

           Stock Price (8/12/2011): 402.90                                                 Share Ty
				
DOCUMENT INFO
Description: Wockhardt Limited (WL) is an India-based an integrated pharmaceutical, biotechnology and healthcare company. The Company is a subsidiary of Khorakwala Holdings and Investments Private Limited. The Company's cardiology division covers lifestyle diseases, which include diabetes and nephrology, supported by biotechnology products, such as Wosulin, Glaritus and Wepox. As of March 31, 2010, the Company had seven hospitals with 800 inpatient beds. The Company's subsidiaries includes Wockhardt Biopharm Limited, Vinton Healthcare Limited, Wockhardt Infrastructure Development Limited, Wockhardt UK Holdings Limited, CP Pharmaceuticals Limited, Wallis Group Limited and The Wallis Laboratory Limited.
BUY THIS DOCUMENT NOW PRICE: $24.95 100% MONEY BACK GUARANTEED
PARTNER Wright Investors' Service
Wright Investors' Service is an internationally recognized investment management and financial advisory firm headquartered in Milford, Connecticut. For more than 40 years, Wright has used well-defined and sophisticated investment strategies to help institutions, plan sponsors, bank trust departments, trust companies and individual investors achieve their financial objectives through a sensible approach to managing assets that balances risk and return.